Cargando…
A Promising Small Molecule for Vanishing White Matter Disease
Investigators from Calico Life Sciences LLC and AbbVie report the effects of a novel drug targeting the genetic basis of Vanishing White Matter Disease (VWMD).
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Pediatric Neurology Briefs Publishers
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6115330/ https://www.ncbi.nlm.nih.gov/pubmed/30174381 http://dx.doi.org/10.15844/pedneurbriefs-32-5 |
| Sumario: | Investigators from Calico Life Sciences LLC and AbbVie report the effects of a novel drug targeting the genetic basis of Vanishing White Matter Disease (VWMD). |
|---|